Biomarkers · Chemical
Influenza B, NAA, Nasopharynx
- LOINC codes
- 76080-1
- Tests that measure Influenza B, NAA, Nasopharynx
- Labcorp 4, Quest Diagnostics 2
Tests
Check the catalog code, specimen, method and preparation for every test that measures Influenza B, NAA, Nasopharynx. Select up to five tests to compare them side by side.
Labcorp 4 tests
Panels that include this biomarker
Influenza A and Influenza B, NAA 140165
2 analytes · Swab · Fasting not stated · Turnaround 2 - 4 days
Labcorp catalog pageMethod and collection
- Method
- Nucleic Acid Amplification (NAA)
- Collection
- For swabs in viral transport medium: Oropharyngeal (OP) samples: Swab included in viral transport medium is acceptable for submission. Nasopharyngeal (NP) samples: Use separate NP swab submitted in viral transport medium (discard OP swab included with viral transport medium). Exact manufacturer of the swab and transport medium may vary with supply. Any swab of appropriate size and configuration with a synthetic tip can be used except for calcium alginate tips, swabs with preservatives, and swabs with wood shafts. Viral transport medium acceptable for collection of influenza specimens in 1 mL or 3 mL volumes can be used to transport swabs for COVID-19 testing. For swabs in saline: OP, NP or anterior nasal swabs may be placed in 1 to 3 mL of sterile saline (0.85 to 0.9%) in a sterile screw cap container. Do not use vacutainer or "pop-top" tubes. Any swab of appropriate size and configuration with a cotton or synthetic tip can be used except for calcium alginate tips, swabs in preservatives, and swabs with wood shafts.
2019 Novel Coronavirus (COVID-19) With Influenza A and Influenza B 140147
3 analytes · Swab · Fasting not stated · Turnaround 1 - 3 days
Labcorp catalog pageMethod and collection
- Method
- Nucleic Acid Amplification (NAA)
- Collection
- Nasopharyngeal (NP) and mid-turbinate swabs: Collect using standard techniques. Place the swab into VTM/UTM and cap tightly. Anterior nasal swab: Insert the tip of the swab into one nostril. The swab does not need to be inserted far. Insert just until the tip of the swab is no longer visible. Rotate the swab in a circle around the entire edge of your nostril at least three times. Repeat with the second nostril. Insert swab into the 0.9% saline tube and cap tightly.
Influenza A, Influenza B and Respiratory Syncytial Virus, NAA 140163
3 analytes · Swab · Fasting not stated · Turnaround 2 - 4 days
Labcorp catalog pageMethod and collection
- Method
- Nucleic Acid Amplification (NAA)
- Collection
- For swabs in viral transport medium: Oropharyngeal (OP) samples: Swab included in viral transport medium is acceptable for submission. Nasopharyngeal (NP) samples: Use separate NP swab submitted in viral transport medium (discard OP swab included with viral transport medium). Exact manufacturer of the swab and transport medium may vary with supply. Any swab of appropriate size and configuration with a synthetic tip can be used except for calcium alginate tips, swabs with preservatives, and swabs with wood shafts. Viral transport medium acceptable for collection of influenza specimens in 1 mL or 3 mL volumes can be used to transport swabs for COVID-19 testing. For swabs in saline: OP, NP or anterior nasal swabs may be placed in 1 to 3 mL of sterile saline (0.85 to 0.9%) in a sterile screw cap container. Do not use vacutainer or "pop-top" tubes. Any swab of appropriate size and configuration with a cotton or synthetic tip can be used except for calcium alginate tips, swabs in preservatives, and swabs with wood shafts.
2019 Novel Coronavirus (COVID-19) With Influenza A, Influenza B and Respiratory Syncytial Virus, NAA 140140
4 analytes · Swab · Fasting not stated · Turnaround 1 - 3 days
Labcorp catalog pageMethod and collection
- Method
- Nucleic Acid Amplification (NAA)
- Collection
- Nasopharyngeal (NP) and mid-turbinate swabs: Collect using standard techniques. Place the swab into VTM/UTM and cap tightly. Anterior nasal swab: Insert the tip of the swab into one nostril. The swab does not need to be inserted far. Insert just until the tip of the swab is no longer visible. Rotate the swab in a circle around the entire edge of your nostril at least three times. Repeat with the second nostril. Insert swab into the 0.9% saline tube and cap tightly.
Quest Diagnostics 2 tests
Panels that include this biomarker
Respiratory Viral Panel, PCR 95512
13 analytes · Swab · Fasting not stated · Turnaround Set up: Mon-Fri a.m.; Report available: 2-5 days
Quest Diagnostics catalog pageMethod and collection
- Method
- LIAISON PLEX System utilizing Reverse Transcription • Polymerase Chain Reaction
- Collection
- Collect NPS specimens with a nylon swab and place into universal transport media or universal viral transport media. Quest Diagnostic Patient Service Centers and Quest in-office phlebotomists do not collect respiratory specimens, including those from patients suspected to have COVID-19. Note: Samples frozen at -70° C may undergo up to 2 freeze/thaw cycles prior to testing with the LIAISON PLEX® Respiratory Flex Assay.
- Reference notes
- See Laboratory Report
Respiratory Pathogen Panel, PCR 37444
16 analytes · Swab · Fasting not stated · Turnaround Set up: Mon-Fri a.m.; Report available: 2-5 days
Quest Diagnostics catalog pageMethod and collection
- Method
- LIAISON PLEX System utilizing Reverse Transcription • Polymerase Chain Reaction
- Collection
- Collect NPS specimens with a nylon swab and place into universal transport media or universal viral transport media. Quest Diagnostic Patient Service Centers and Quest in-office phlebotomists do not collect respiratory specimens, including those from patients suspected to have COVID-19. Note: Samples frozen at -70° C may undergo up to 2 freeze/thaw cycles prior to testing with the LIAISON PLEX® Respiratory Flex Assay.
- Reference notes
- See Laboratory Report
0 of 5 tests selected
Pick one moreSources
4 tests: codes, specimens, methods, preparation and reference intervals.
Quest Diagnostics test catalog
2 tests: codes, specimens, methods, preparation and reference intervals.
LOINC 76080-1
Regenstrief Institute codes that identify the same result across labs.
Search ClinicalTrials.gov for Influenza B, NAA, Nasopharynx
Registered studies that measure Influenza B, NAA, Nasopharynx, on the U.S. National Library of Medicine registry.
Verify these ranges and sources
We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.
Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.